Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor

Cancer Investigation

Volumn 16, Issue 4, 1998, Pages 225-230

  Pham, Christine D ^a   Roberts, Timothy P L ^a   Van Bruggen, Nick ^b   Melnyk, Ostap ^a   Mann, Jeffry ^a   Ferrara, Napoleon ^b   Cohen, Robert L ^b   Brasch, Robert C ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR GROWTH;

EID: 0031946469     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809039771     Document Type: Article

References (14)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6, 1990.
2. Dvorak HF, Brown LF, Detmar M, et al: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperper-meability, and angiogenesis. Am J Pathol 146:1029-1039, 1995.
3. Nagy JA, Brown LF, Senger DR, et al: Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948:305-326, 1988.
4. Kim KJ, Li B, Winer J, et al: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844, 1993.
5. Warren RS, Yuan H, Matli MR, et al: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95:1789-1797, 1995.
6. Melnyk O, Shuman MA, Kim KJ: Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res 56:921-924, 1996.
7. Kim KJ, Li B, Houck K, et al: The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7:53-64, 1992.
8. Senger DR, Perruzzi CA, Feder J, et al: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5633, 1986.
9. Schwickert HC, Stiskal M, Roberts TP, et al: Contrast-enhanced MRI imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy. Radiology 198: 893-898, 1996.
10. Schwickert HC, Roberts TPL, Shames DM, et al: Quantification of liver blood volume: comparison of ultra short T1 inversion recovery echoplanar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 34:845-852, 1995.
11. Shames DM, Kuwatsuru R, Vexier V, et al: Measurement of capillary permeability to macromolecules by dynamic resonance imaging: A quantitative non-invasive technique. Magn Reson Med 29:616-622, 1993.
12. Price JE, Polyzos A, Zhang RD, et al: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50:717-721, 1990.
13. Ingber D, Fujita T, Kishimoto S, et al: Synthetic analogues of fumagilin that inhibit angiogenesis and suppress tumor growth. Nature 348:555-557, 1990.
14. Ogan MD, Schmiedl U, Moseley ME, et al: Albumin labeled with Gd-DTPA-an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 22:665-671, 1987.